177 related articles for article (PubMed ID: 24381058)
1. Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro.
Dong L; Wang F; Yin X; Chen L; Li G; Lin F; Ni W; Wu J; Jin R; Jiang L
Mol Cell Biochem; 2014 Apr; 389(1-2):257-64. PubMed ID: 24381058
[TBL] [Abstract][Full Text] [Related]
2. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P.
Lin F; Zhang P; Zuo Z; Wang F; Bi R; Shang W; Wu A; Ye J; Li S; Sun X; Wu J; Jiang L
Cancer Lett; 2017 Aug; 401():1-10. PubMed ID: 28483515
[TBL] [Abstract][Full Text] [Related]
4. A Novel DNA Aptamer Targeting S100P Induces Antitumor Effects in Colorectal Cancer Cells.
Sun W; Luo L; Fang D; Tang T; Ni W; Dai B; Sun H; Jiang L
Nucleic Acid Ther; 2020 Dec; 30(6):402-413. PubMed ID: 32991252
[TBL] [Abstract][Full Text] [Related]
5. S100P, a calcium-binding protein, is preferentially associated with the growth of polypoid tumors in colorectal cancer.
Chiang JM; Tan R; Wang JY; Chen JS; Lee YS; Hsieh PS; Changchien CR; Chen JR
Int J Mol Med; 2015 Mar; 35(3):675-83. PubMed ID: 25585623
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
7. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages.
Wang Q; Zhang JG; Wang W
Genet Mol Res; 2015 Jun; 14(2):6844-51. PubMed ID: 26125892
[TBL] [Abstract][Full Text] [Related]
9. Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells.
Ni X; Chen J; Lu F; Yuan Z; Xu X; Hu Z; Jiang L
Recent Pat Anticancer Drug Discov; 2018; 13(2):240-247. PubMed ID: 29600769
[TBL] [Abstract][Full Text] [Related]
10. S100P, a potential novel prognostic marker in colorectal cancer.
Wang Q; Zhang YN; Lin GL; Qiu HZ; Wu B; Wu HY; Zhao Y; Chen YJ; Lu CM
Oncol Rep; 2012 Jul; 28(1):303-10. PubMed ID: 22552710
[TBL] [Abstract][Full Text] [Related]
11. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.
Schmid F; Dahlmann M; Röhrich H; Kobelt D; Hoffmann J; Burock S; Walther W; Stein U
Br J Cancer; 2022 Sep; 127(4):675-685. PubMed ID: 35597866
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
[TBL] [Abstract][Full Text] [Related]
13. S100P predicts prognosis and drug resistance in gastric cancer.
Ge F; Wang C; Wang W; Wu B
Int J Biol Markers; 2013 Dec; 28(4):e387-92. PubMed ID: 23722300
[TBL] [Abstract][Full Text] [Related]
14. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
[TBL] [Abstract][Full Text] [Related]
15. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
[TBL] [Abstract][Full Text] [Related]
16. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
17. S100P as a marker for poor survival and advanced stage in gallbladder carcinoma.
Mathai AM; Alexander J; Huang HY; Li CF; Jeng YM; Fung KM; Harris WP; Swanson PE; Truong C; Yeh MM
Ann Diagn Pathol; 2021 Jun; 52():151736. PubMed ID: 33798925
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase D1 Correlates with Less Lymph Node Metastasis Risk, Enhanced 5-FU Sensitivity, and Better Prognosis in Colorectal Cancer.
Huang B; He Z
Tohoku J Exp Med; 2023 Aug; 260(4):305-314. PubMed ID: 37225445
[TBL] [Abstract][Full Text] [Related]
19. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
20. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
